Aroa Biosurgery Limited - Laporan Laba Rugi (TTM)

Aroa Biosurgery Limited
AU ˙ ASX
A$ 0.65 0.00 (0.00%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Aroa Biosurgery Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
Revenue 21 22 22 27 31 35 40 45 51 57 63 65 66 67 69 73 76 81 85
Change (%) 2.97 2.88 19.41 16.25 13.97 12.26 14.47 12.64 11.92 10.65 2.00 1.96 2.41 2.35 5.27 5.01 5.47 5.18
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 6 7 7 7 8 9 9 10 10 10 10 10 10 10 10 10 10 11 12
Change (%) 3.04 2.95 9.08 8.32 8.20 7.58 1.78 1.74 0.90 0.89 1.76 1.73 -0.67 -0.68 0.55 0.55 9.20 8.43
% of Revenue 30.47 30.50 30.52 27.88 25.98 24.66 23.63 21.01 18.98 17.11 15.60 15.56 15.53 15.06 14.61 13.96 13.37 13.84 14.27
Gross Operating Profit 15 15 16 19 23 27 30 36 41 47 53 55 56 57 59 63 66 69 73
Change (%) 2.93 2.85 23.94 19.32 16.00 13.79 18.40 15.54 14.50 12.66 2.04 2.00 2.97 2.89 6.08 5.73 4.89 4.66
% of Revenue 69.53 69.50 69.48 72.12 74.02 75.34 76.37 78.99 81.02 82.89 84.40 84.44 84.47 84.94 85.39 86.04 86.63 86.16 85.73
SG&A 20 21 22 24 26 28 31 34 37 42 48 52 56 59 62 65 68 67 67
Change (%) 5.60 5.30 9.33 8.54 9.46 8.65 10.71 9.68 13.97 12.26 8.18 7.56 5.98 5.64 4.64 4.43 -0.63 -0.64
% of Revenue 92.78 95.15 97.39 89.17 83.26 79.96 77.39 74.85 72.88 74.22 75.30 79.86 84.24 87.18 89.98 89.44 88.95 83.80 79.16
R&D 5 6 6 7 7 8 8 10 11 11 11 10 10 9 9 9 9 9 10
Change (%) 9.95 9.05 6.44 6.05 7.60 7.06 14.23 12.45 -0.55 -0.56 -4.21 -4.39 -2.88 -2.97 1.43 1.41 0.77 0.76
% of Revenue 25.41 27.13 28.76 25.63 23.38 22.08 21.05 21.01 20.97 18.64 16.75 15.73 14.75 13.99 13.26 12.78 12.34 11.79 11.29
OpEx 30 31 32 36 40 44 47 52 56 61 66 70 74 77 80 83 86 87 88
Change (%) 4.16 4.00 12.22 10.89 8.83 8.11 9.12 8.36 9.40 8.59 5.29 5.03 4.24 4.06 4.08 3.92 0.79 0.78
% of Revenue 141.46 143.11 144.66 135.95 129.68 123.83 119.26 113.68 109.36 106.90 104.91 108.30 111.56 113.55 115.45 114.15 112.97 107.96 103.45
Operating Income -9 -9 -10 -10 -9 -8 -8 -6 -5 -4 -3 -5 -8 -9 -11 -10 -10 -6 -3
Change (%) 7.05 6.59 -3.87 -4.02 -8.49 -9.28 -18.67 -22.96 -17.52 -21.24 72.39 41.99 20.07 16.71 -3.61 -3.75 -35.26 -54.47
% of Revenue -41.46 -43.11 -44.66 -35.95 -29.68 -23.83 -19.26 -13.68 -9.36 -6.90 -4.91 -8.30 -11.56 -13.55 -15.45 -14.15 -12.97 -7.96 -3.45
Interest Expense -3 -2 -2 -2 -2 -1 -1 -1 -0 -0 -0 -0 -0 -0 -0 -0 -1 -0 -0
Change (%) -13.14 -15.13 -4.33 -4.52 -16.99 -20.47 -33.52 -50.43 -0.13 -0.13 6.22 5.85 7.65 7.10 1.84 1.80 -3.15 -3.25
% of Revenue -12.27 -10.35 -8.54 -6.84 -5.62 -4.09 -2.90 -1.68 -0.74 -0.66 -0.60 -0.62 -0.64 -0.68 -0.71 -0.69 -0.67 -0.61 -0.56
Net Income -19 -19 -19 -15 -11 -10 -8 -5 -2 -1 -0 -4 -8 -9 -11 -9 -8 -6 -4
Change (%) 1.71 1.68 -21.88 -28.00 -11.19 -12.60 -39.80 -66.13 -38.42 -62.39 996.59 90.88 14.11 12.36 -14.17 -16.51 -24.97 -33.28
% of Revenue -88.07 -86.99 -85.98 -56.25 -34.84 -27.15 -21.13 -11.11 -3.34 -1.84 -0.62 -6.72 -12.58 -14.02 -15.39 -12.55 -9.97 -7.10 -4.50

Source: Capital IQ

Other Listings
US:AROAF
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista